Compounds > zirconium
Page last updated: 2024-08-22

zirconium and Breast Neoplasms

zirconium has been researched along with Breast Neoplasms in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.23)18.7374
1990's0 (0.00)18.2507
2000's2 (6.45)29.6817
2010's25 (80.65)24.3611
2020's3 (9.68)2.80

Authors

AuthorsStudies
Baas, IO; Boellaard, R; Borra, RJH; Brouwers, AH; Dierckx, RAJO; Glaudemans, AWJM; Lammertsma, AA; Schröder, CP; Tsoumpas, C; van Sluis, J; van Snick, JH1
Bhanot, U; Biachi De Castria, T; Bojilova, V; Capanu, M; Ceglia, N; Chatila, W; Chou, JF; Do, RKG; Elzein, A; Feder, L; Hechtman, JF; Ilson, DH; Janjigian, YY; Kim, K; Ku, GY; Lee, J; Lewis, JS; Maron, SB; Merghoub, T; Nagy, RJ; Pandit-Taskar, N; Paroder, V; Ptashkin, R; Sabwa, S; Schultz, N; Schulze, I; Segal, M; Shah, S; Simmons, M; Socolow, F; Solit, DB; Thomas, J; Walch, H; Zatzman, M1
Cingoranelli, SJ; Ducharme, M; Eckenroad, W; Hall, L; Houson, HA; Hunter, C; Jaskowski, L; Lapi, SE; Larimer, BM1
Hosseinzadeh, R; Khorsandi, K1
Fletcher, NL; Houston, ZH; Simpson, JD; Thurecht, KJ; Veedu, RN1
Adumeau, P; Fung, K; Rodriguez, C; Sharma, SK; Vivier, D; Zeglis, BM1
Du, M; Gu, C; Guo, C; He, L; Li, Z; Wang, M; Zhang, Z; Zhou, N1
Chang, W; Huang, H; Jia, Q; Qiao, C; Wang, H; Wang, Y; Wang, Z; Zhang, H; Zhang, R1
Bhattacharyya, S; Doroshow, JH; Hill, GC; Jacobs, PM; Kalen, JD; Kaur, G; Kurdziel, K; Riffle, L; Tatum, JL; Wei, L1
Cloutier, G; Ekeom, D; Hadj Henni, A1
Bart, J; Brouwers, AH; de Jong, JR; de Vries, EG; de Vries, J; Gaykema, SB; Jansen, L; Lub-de Hooge, MN; Pleijhuis, RG; Pot, L; Schröder, CP; Timmer-Bosscha, H; van Dam, GM; van der Meulen, SB1
Báez, A; Clearfield, A; Colón, JL; David, A; Díaz, A; González, ML; Mukherjee, A; Pérez, RJ1
Hari-Raj, A; Ikotun, OF; Lapi, SE; Marquez, BV; Pierce, RA; Wright, B; Zheleznyak, A1
Akimov, M; Banerji, U; Bongaerts, AH; Brouwers, AH; Chua, S; de Vries, EG; Fernandez-Ibarra, C; Gaykema, SB; Lub-de Hooge, MN; Oude Munnink, TH; Schröder, CP; Swanton, C; Vitfell-Rasmussen, J1
Blower, PJ; Charoenphun, P; Ferris, TJ; Meszaros, LK; Mullen, GE; Went, MJ1
Gehring, T; Mendler, CT; Schwaiger, M; Skerra, A; Wester, HJ1
Burton-Pye, BP; Cicek, HT; Deri, MA; Francesconi, LC; Hu, C; Kozlowski, P; Lewis, JS; Ponnala, S1
Cullinane, C; Donnelly, PS; Hicks, RJ; Roselt, P; Rudd, SE1
Baguña-Torres, J; Blower, PJ; Edmonds, S; Fruhwirth, GO; Gabizon, A; Livieratos, L; Maher, J; Parente-Pereira, AC; Radia, R; Severin, GW; Shmeeda, H; Szanda, I; T M de Rosales, R; Volpe, A1
Darwish, M; Flores, JE; Gill, HS; Junutula, JR; Luis, E; Marik, J; Ogasawara, A; Tinianow, JN; Vanderbilt, AN; Vandlen, R; Williams, SP1
Brouwers, AH; de Jong, JR; de Vries, EG; Dijkers, EC; Jager, PL; Kosterink, JG; Lub-de Hooge, MN; Oude Munnink, TH; Schröder, CP; van Dongen, GA1
Feng, S; Goodison, S; Liu, Y; Lubman, DM; Vuong, H; Xie, X1
Brouwers, AH; de Vries, EG; Dijkers, EC; Haasjes, JG; Lub-de Hooge, MN; Netters, SJ; Oude Munnink, TH; Schröder, CP1
Báez, A; Clearfield, A; Colón, JL; David, A; Díaz, A; González, ML; Pérez, R; Wark, SE; Zhang, P1
Shih, WH; Shih, WY; Yegingil, H1
Arjaans, ME; de Vries, EG; Gregory, RC; Hesselink, JW; Lub-de Hooge, MN; Oude Munnink, TH; Reiss, M; Schröder, CP; Timmer-Bosscha, H; Vedelaar, SR; Walenkamp, AM1
Batteas, JD; Carpenter, C; Casañas, B; Clearfield, A; Colón, JL; David, A; Díaz, A; González, J; Hussain, MD; Saxena, V1
Barnhart, TE; Cai, W; Chen, X; Engle, JW; Hong, H; Leigh, BR; Nickles, RJ; Niu, G; Severin, GW; Yang, Y; Zhang, Y1
Albert, BJ; Czaicki, NL; Koide, K; Naka, T; Sivaramakrishnan, A1
Saito, M1
Hansen, HJ; Krupey, J; Lo Gerfo, P1

Trials

2 trial(s) available for zirconium and Breast Neoplasms

ArticleYear
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2023, 09-15, Volume: 29, Issue:18

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Esophageal Neoplasms; Female; Humans; Programmed Cell Death 1 Receptor; Radioisotopes; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab; Zirconium

2023
89Zr-bevacizumab PET imaging in primary breast cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:7

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Bevacizumab; Biomarkers, Tumor; Breast Neoplasms; Feasibility Studies; Female; Humans; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Vascular Endothelial Growth Factor A; Zirconium

2013

Other Studies

29 other study(ies) available for zirconium and Breast Neoplasms

ArticleYear
First-time imaging of [
    European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:10

    Topics: Breast Neoplasms; Female; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Receptor, ErbB-2; Tomography, X-Ray Computed; Trastuzumab; Zirconium

2022
Evaluation of [
    Molecular pharmaceutics, 2023, 09-04, Volume: 20, Issue:9

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Positron-Emission Tomography; Receptor, ErbB-2; Single-Domain Antibodies; Tissue Distribution; Trastuzumab; Zirconium

2023
Photodynamic effect of Zirconium phosphate biocompatible nano-bilayers containing methylene blue on cancer and normal cells.
    Scientific reports, 2019, 10-17, Volume: 9, Issue:1

    Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Compounding; Drug Screening Assays, Antitumor; Humans; Methylene Blue; Microscopy, Electron, Scanning; Nanoparticles; Photochemotherapy; Photosensitizing Agents; X-Ray Diffraction; Zirconium

2019
Designed multifunctional polymeric nanomedicines: long-term biodistribution and tumour accumulation of aptamer-targeted nanomaterials.
    Chemical communications (Cambridge, England), 2018, Oct-11, Volume: 54, Issue:82

    Topics: Animals; Aptamers, Nucleotide; Breast Neoplasms; Cell Line; Drug Delivery Systems; Female; Humans; Mice, Inbred BALB C; Mice, Nude; Molecular Imaging; Nanostructures; Polyethylene Glycols; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Vascular Endothelial Growth Factor A; Zirconium

2018
The Impact of FcγRI Binding on Immuno-PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019, Volume: 60, Issue:8

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Deferoxamine; Female; Glycosylation; Humans; Immunoconjugates; Immunoglobulin G; In Vitro Techniques; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, IgG; Recombinant Proteins; Surface Plasmon Resonance; Tissue Distribution; Trastuzumab; Zirconium

2019
Bimetallic ZrHf-based metal-organic framework embedded with carbon dots: Ultra-sensitive platform for early diagnosis of HER2 and HER2-overexpressed living cancer cells.
    Biosensors & bioelectronics, 2019, Jun-01, Volume: 134

    Topics: Aptamers, Nucleotide; Biosensing Techniques; Breast Neoplasms; Carbon; Early Detection of Cancer; Female; Hafnium; Humans; Limit of Detection; MCF-7 Cells; Metal-Organic Frameworks; Nanostructures; Receptor, ErbB-2; Reproducibility of Results; Zirconium

2019
Highly Stable and Long-Circulating Metal-Organic Frameworks Nanoprobes for Sensitive Tumor Detection In Vivo.
    Advanced healthcare materials, 2019, Volume: 8, Issue:19

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Lipid Bilayers; Materials Testing; Metal-Organic Frameworks; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Nanostructures; Neoplasm Transplantation; Neoplasms; Phosphatidic Acids; Polyethylene Glycols; Surface Properties; Zirconium

2019
Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas.
    Nuclear medicine and biology, 2013, Volume: 40, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoconjugates; Isotope Labeling; Male; Mice; Panitumumab; Pentetic Acid; Positron-Emission Tomography; Radioisotopes; Radiometry; Zirconium

2013
Design of a phased array for the generation of adaptive radiation force along a path surrounding a breast lesion for dynamic ultrasound elastography imaging.
    IEEE transactions on ultrasonics, ferroelectrics, and frequency control, 2013, Volume: 60, Issue:3

    Topics: Breast Neoplasms; Computer Simulation; Elasticity Imaging Techniques; Electric Impedance; Female; Humans; Lead; Titanium; Transducers; Zirconium

2013
Direct intercalation of cisplatin into zirconium phosphate nanoplatelets for potential cancer nanotherapy.
    Nanoscale, 2013, Dec-07, Volume: 5, Issue:23

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Cisplatin; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Intercalating Agents; MCF-7 Cells; Metal Nanoparticles; Zirconium

2013
Evaluation of (89)Zr-pertuzumab in Breast cancer xenografts.
    Molecular pharmaceutics, 2014, Nov-03, Volume: 11, Issue:11

    Topics: Animals; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Carrier Proteins; Female; Humans; Immunoenzyme Techniques; Mice; Mice, SCID; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Spectrometry, Mass, Electrospray Ionization; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zirconium

2014
89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Aug-01, Volume: 20, Issue:15

    Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Breast Neoplasms; Clinical Trials, Phase II as Topic; Female; Follow-Up Studies; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radioisotopes; Resorcinols; Zirconium

2014
Synthesis and characterisation of zirconium complexes for cell tracking with Zr-89 by positron emission tomography.
    Dalton transactions (Cambridge, England : 2003), 2014, Oct-21, Volume: 43, Issue:39

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Tracking; Chromatography, High Pressure Liquid; Coordination Complexes; Female; Humans; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Zirconium

2014
⁸⁹Zr-Labeled Versus ¹²⁴I-Labeled αHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:7

    Topics: Amino Acids; Animals; Antibodies, Monoclonal; Breast Neoplasms; Contrast Media; Female; Half-Life; Humans; Immunoglobulin Fab Fragments; Iodine Radioisotopes; Isotope Labeling; Mice; Neoplasm Transplantation; Neoplasms; Positron-Emission Tomography; Prognosis; Radioisotopes; Radiopharmaceuticals; Recombinant Proteins; Tissue Distribution; Zirconium

2015
p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET.
    Bioconjugate chemistry, 2015, Dec-16, Volume: 26, Issue:12

    Topics: Animals; Breast; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Deferoxamine; Female; Humans; Immunoconjugates; Mice, Nude; Models, Molecular; Positron-Emission Tomography; Pyridones; Tissue Distribution; Trastuzumab; Zirconium

2015
A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies.
    Chemical communications (Cambridge, England), 2016, Sep-29, Volume: 52, Issue:80

    Topics: Animals; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Deferoxamine; Disease Models, Animal; Female; Humans; Isotope Labeling; Mice; Positron-Emission Tomography; Radioisotopes; Receptor, ErbB-2; Transplantation, Heterologous; Trastuzumab; Zirconium

2016
Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines.
    ACS nano, 2016, 11-22, Volume: 10, Issue:11

    Topics: Breast Neoplasms; Copper Radioisotopes; Female; Humans; Liposomes; Manganese; Nanomedicine; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Zirconium

2016
Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET.
    Nuclear medicine and biology, 2010, Volume: 37, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Female; Humans; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Positron-Emission Tomography; Radioimmunodetection; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Zirconium

2010
Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer.
    Clinical pharmacology and therapeutics, 2010, Volume: 87, Issue:5

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cohort Studies; Feasibility Studies; Female; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radioisotopes; Receptor, ErbB-2; Tissue Distribution; Trastuzumab; Zirconium

2010
A comparative phosphoproteomic analysis of a human tumor metastasis model using a label-free quantitative approach.
    Electrophoresis, 2010, Volume: 31, Issue:11

    Topics: Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cluster Analysis; Humans; Models, Biological; Neoplasm Metastasis; Neoplasm Proteins; Peptide Fragments; Phenotype; Phosphoproteins; Phosphorylation; Proteomics; Reproducibility of Results; Signal Transduction; Tandem Mass Spectrometry; Titanium; Zirconium

2010
Trastuzumab pharmacokinetics influenced by extent human epidermal growth factor receptor 2-positive tumor load.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jul-20, Volume: 28, Issue:21

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Radioisotopes; Receptor, ErbB-2; Trastuzumab; Zirconium

2010
Nanoencapsulation of insulin into zirconium phosphate for oral delivery applications.
    Biomacromolecules, 2010, Sep-13, Volume: 11, Issue:9

    Topics: Animals; Breast Neoplasms; Cattle; Cell Survival; Circular Dichroism; Female; Humans; Hypoglycemic Agents; Insulin; Intercalating Agents; Microscopy, Electron, Scanning; Nanocapsules; Nanotechnology; Pancreas; Rats; Spectroscopy, Fourier Transform Infrared; Tumor Cells, Cultured; Zirconium

2010
Probing model tumor interfacial properties using piezoelectric cantilevers.
    The Review of scientific instruments, 2010, Volume: 81, Issue:9

    Topics: Aluminum Silicates; Anisotropy; Biomechanical Phenomena; Breast Neoplasms; Clay; Elastic Modulus; Electricity; Lead; Models, Anatomic; Neoplasm Invasiveness; Phantoms, Imaging; Shear Strength; Titanium; Zirconium

2010
PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:12

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Humans; Isotope Labeling; Liver; Male; Mice; Neoplasm Metastasis; Positron-Emission Tomography; Radioisotopes; Transfection; Transforming Growth Factor beta; Zirconium

2011
Zirconium phosphate nano-platelets: a novel platform for drug delivery in cancer therapy.
    Chemical communications (Cambridge, England), 2012, Feb-07, Volume: 48, Issue:12

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; Female; Humans; Nanostructures; Zirconium

2012
Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW.
    Molecular pharmaceutics, 2012, Aug-06, Volume: 9, Issue:8

    Topics: Animals; Benzenesulfonates; Breast Neoplasms; Cell Line, Tumor; Female; Flow Cytometry; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Lung Neoplasms; Mice; Mice, Inbred BALB C; Zirconium

2012
Total syntheses, fragmentation studies, and antitumor/antiproliferative activities of FR901464 and its low picomolar analogue.
    Journal of the American Chemical Society, 2007, Mar-07, Volume: 129, Issue:9

    Topics: Alkadienes; Alkenes; Alkynes; Allyl Compounds; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Epoxy Compounds; Furans; Humans; Inhibitory Concentration 50; Models, Chemical; Oxidation-Reduction; Pyrans; Silver; Spiro Compounds; Stereoisomerism; Zirconium

2007
Dual-energy approach to contrast-enhanced mammography using the balanced filter method: spectral optimization and preliminary phantom measurement.
    Medical physics, 2007, Volume: 34, Issue:11

    Topics: Breast; Breast Neoplasms; Contrast Media; Equipment Design; Female; Humans; Iodine; Mammography; Neodymium; Phantoms, Imaging; Radiographic Image Enhancement; Radiography, Dual-Energy Scanned Projection; Subtraction Technique; Tungsten; X-Rays; Zirconium

2007
Demonstration of an antigen common to several varieties of neoplasia.
    The New England journal of medicine, 1971, Jul-15, Volume: 285, Issue:3

    Topics: Adenocarcinoma; Aged; Animals; Antigens; Antigens, Neoplasm; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Embryo, Mammalian; Female; Gels; Goats; Humans; Immune Sera; Iodine Isotopes; Lung Neoplasms; Male; Methods; Middle Aged; Neoplasms; Phosphates; Pregnancy; Prostatic Neoplasms; Radioimmunoassay; Zirconium

1971